UPB CIK: 2022626

Upstream Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
117
FY24:
479
FY25:
352
(positive)
Change from FY23 to FY25
millions USD
FY23:
0.20
FY24:
2.56
FY25:
1.98
Total assets
Change from FY23 to FY25
millions USD
FY23:
117
FY24:
482
FY25:
354

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
6.52
FY24:
10.7
FY25:
13.5
(negative)
Change from FY23 to FY25
millions USD
FY23:
2.87
FY24:
1.13
FY25:
0.55
(positive)
Change from FY23 to FY25
millions USD
FY23:
−123
FY24:
470
FY25:
340
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
482
FY25:
354

All amounts in millions USD Data source:SEC EDGAR